|
| 37551911 | Biomedical relation extraction with knowledge base-refined weak supervision. | Database (Oxford) | 2023 |
| 36385925 | Discovery of 5,7-Dihydro-6<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors. | ACS Med Chem Lett | 2022 |
| 34083538 | Crowdsourced mapping of unexplored target space of kinase inhibitors. | Nat Commun | 2021 |
| 33600552 | Correction: The deubiquitylase USP9X controls ribosomal stalling. | J Cell Biol | 2021 |
| 33507233 | The deubiquitylase USP9X controls ribosomal stalling. | J Cell Biol | 2021 |
| 34868947 | Deep-Learning-Based Natural Language Processing of Serial Free-Text Radiological Reports for Predicting Rectal Cancer Patient Survival. | Front Oncol | 2021 |
| 34636321 | USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma. | Elife | 2021 |
| 34252937 | Predicting mechanism of action of novel compounds using compound structure and transcriptomic signature coembedding. | Bioinformatics | 2021 |
| 31501885 | BioBERT: a pre-trained biomedical language representation model for biomedical text mining. | Bioinformatics | 2020 |
| 31680157 | ChimerDB 4.0: an updated and expanded database of fusion genes. | Nucleic Acids Res | 2020 |
| 32657401 | Improved survival analysis by learning shared genomic information from pan-cancer data. | Bioinformatics | 2020 |
| 32591513 | Building a PubMed knowledge graph. | Sci Data | 2020 |
| 32292577 | Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models. | Oncotarget | 2020 |
| 31116384 | ReSimNet: drug response similarity prediction using Siamese neural networks. | Bioinformatics | 2019 |
| 29368597 | Deep learning of mutation-gene-drug relations from the literature. | BMC Bioinformatics | 2018 |
| 30443290 | The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models. | Oncotarget | 2018 |
| 29697361 | Mut2Vec: distributed representation of cancerous mutations. | BMC Med Genomics | 2018 |
| 29562737 | Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. | J Med Chem | 2018 |
| 29560824 | In silico drug combination discovery for personalized cancer therapy. | BMC Syst Biol | 2018 |
| 27899563 | ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining. | Nucleic Acids Res | 2017 |
| 28296398 | Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer. | J Med Chem | 2017 |
| 28151717 | Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia. | Clin Cancer Res | 2017 |
| 29045389 | Molecular basis of USP7 inhibition by selective small-molecule inhibitors. | Nature | 2017 |
| 27986745 | Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma. | Clin Cancer Res | 2017 |
| 27729458 | Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma. | Clin Cancer Res | 2017 |
| 27074804 | BRONCO: Biomedical entity Relation ONcology COrpus for extracting gene-variant-disease-drug relations. | Database (Oxford) | 2016 |
| 27760149 | BEST: Next-Generation Biomedical Entity Search Tool for Knowledge Discovery from Biomedical Literature. | PLoS One | 2016 |
| 27485446 | HiPub: translating PubMed and PMC texts to networks for knowledge discovery. | Bioinformatics | 2016 |
| 26337082 | Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. | Oncotarget | 2015 |
| 24362935 | Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma. | Nat Med | 2014 |
| 25344755 | Cyclin C is a haploinsufficient tumour suppressor. | Nat Cell Biol | 2014 |
| 25002028 | CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors. | Cancer Cell | 2014 |
| 25028469 | Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo. | Mol Cancer Ther | 2014 |
| 23842682 | An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). | Cancer Discov | 2013 |
| 24045179 | Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. | Clin Cancer Res | 2013 |
| 24900493 | Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors. | ACS Med Chem Lett | 2012 |
| 21038853 | 4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6. | J Med Chem | 2010 |
| 16724057 | Validating cancer drug targets. | Nature | 2006 |
| 15894405 | Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times. | Peptides | 2005 |
| 15126329 | Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides. | Cancer Res | 2004 |
| 14571120 | Synergistic inhibitory effect of cationic peptides and antimicrobial agents on the growth of oral streptococci. | Caries Res | 2003 |
| 14499271 | In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. | Peptides | 2003 |
| 14534293 | Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors. | J Biol Chem | 2003 |
| 12234496 | Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases. | Arch Biochem Biophys | 2002 |
| 11682065 | Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata. | FEBS Lett | 2001 |
| 10691971 | Ligand binding inhibitors of A1 adenosine receptor from Rana rugosa are phospholipase A2s. | Eur J Biochem | 2000 |